Tapewire

Nasdaq · USD

ANAB

ANAPTYSBIO, INC

Export transactions ↓
Tapewire entity
4640
SEC CIK
0001370053
Parsed reports
295

Last 12 months

Inside the activity.

0 purchase rows · 42 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 2025010
Jan 2026017
Feb 202601
Mar 2026013
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 06, 2025 Filed Jan 7, 2025 22:27 UTC
Faga DanielDirector · President, CEO
Exercise / conversionCommon Stock 17,850 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001034 · form4-01072025_100123.xml · nonDerivative · entry 3

Faga Daniel · CIK 0001673528 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 442,853

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
January 06, 2025 Filed Jan 7, 2025 17:32 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 5,545 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001042 · form4-01072025_100105.xml · derivative · entry 6

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,090

Underlying: Common Stock · 5,545 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F6 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F6 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2025 Filed Jan 7, 2025 17:32 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
Tax withholdingCommon Stock 2,217 $15.30 $33,920.10
Disclosure

SEC source: 0001415889-25-001042 · form4-01072025_100105.xml · nonDerivative · entry 4

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,003

F3 · shares: Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation.

F4 · shares: The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes.

Read SEC document
January 06, 2025 Filed Jan 7, 2025 17:32 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
Exercise / conversionCommon Stock 5,545 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001042 · form4-01072025_100105.xml · nonDerivative · entry 3

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,220

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
January 06, 2025 Filed Jan 7, 2025 22:32 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 5,245 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001044 · form4-01072025_100138.xml · derivative · entry 6

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,490

Underlying: Common Stock · 5,245 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F6 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F6 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2025 Filed Jan 7, 2025 22:32 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 2,054 $15.30 $31,426.20
Disclosure

SEC source: 0001415889-25-001044 · form4-01072025_100138.xml · nonDerivative · entry 4

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,802

F3 · shares: Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation.

F4 · shares: The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes.

Read SEC document
January 06, 2025 Filed Jan 7, 2025 22:32 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 5,245 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001044 · form4-01072025_100138.xml · nonDerivative · entry 3

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,856

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:33 UTC
Lizzul Paul F.Chief Medical Officer
Exercise / conversionRestricted Stock Unit · Derivative 10,555 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001046 · form4-01072025_100117.xml · derivative · entry 5

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,665

Underlying: Common Stock · 10,555 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F5 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F5 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:33 UTC
Lizzul Paul F.Chief Medical Officer
Tax withholdingCommon Stock 4,336 $14.60 $63,305.60
Disclosure

SEC source: 0001415889-25-001046 · form4-01072025_100117.xml · nonDerivative · entry 2

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,759

F3 · shares: Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation.

F4 · shares: The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:33 UTC
Lizzul Paul F.Chief Medical Officer
Exercise / conversionCommon Stock 10,555 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001046 · form4-01072025_100117.xml · nonDerivative · entry 1

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,095

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · balance_after: Reflects the acquisition of 142 shares acquired under the Company's ESPP.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:27 UTC
Faga DanielDirector · President, CEO
Exercise / conversionRestricted Stock Unit · Derivative 34,678 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001034 · form4-01072025_100123.xml · derivative · entry 5

Faga Daniel · CIK 0001673528 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,032

Underlying: Common Stock · 34,678 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F5 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F5 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:27 UTC
Faga DanielDirector · President, CEO
Tax withholdingCommon Stock 13,033 $14.60 $190,281.80
Disclosure

SEC source: 0001415889-25-001034 · form4-01072025_100123.xml · nonDerivative · entry 2

Faga Daniel · CIK 0001673528 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 425,003

F3 · shares: Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation.

F4 · shares: The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:27 UTC
Faga DanielDirector · President, CEO
Exercise / conversionCommon Stock 34,678 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001034 · form4-01072025_100123.xml · nonDerivative · entry 1

Faga Daniel · CIK 0001673528 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 438,036

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · balance_after: Reflects the acquisition of 212 shares acquired under the Company's ESPP.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 17:32 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 7,288 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001042 · form4-01072025_100105.xml · derivative · entry 5

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,862

Underlying: Common Stock · 7,288 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F5 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F5 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 17:32 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
Tax withholdingCommon Stock 2,994 $14.60 $43,712.40
Disclosure

SEC source: 0001415889-25-001042 · form4-01072025_100105.xml · nonDerivative · entry 2

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,675

F3 · shares: Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation.

F4 · shares: The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 17:32 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
Exercise / conversionCommon Stock 7,288 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001042 · form4-01072025_100105.xml · nonDerivative · entry 1

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,669

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · balance_after: Reflects the acquisition of 141 shares acquired under the Company's ESPP.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:32 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 8,293 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001044 · form4-01072025_100138.xml · derivative · entry 5

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,877

Underlying: Common Stock · 8,293 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F5 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F5 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:32 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 3,407 $14.60 $49,742.20
Disclosure

SEC source: 0001415889-25-001044 · form4-01072025_100138.xml · nonDerivative · entry 2

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,611

F3 · shares: Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation.

F4 · shares: The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:32 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 8,293 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001044 · form4-01072025_100138.xml · nonDerivative · entry 1

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,018

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · balance_after: Reflects the acquisition of 981 shares acquired under the Company's ESPP.

Read SEC document
January 02, 2025 Filed Jan 2, 2025 18:17 UTC
EcoR1 Capital, LLCDirector · 10% owner
NODELMAN OLEGDirector · 10% owner
PurchaseCommon Stock 6,646 $12.95 $86,069.69
Disclosure

SEC source: 0000935836-25-000008 · ownership.xml · nonDerivative · entry 3

EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner

NODELMAN OLEG · CIK 0001454385 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Note

Disclosed balance after: 7,880,094

F7 · shares: Qualified Fund purchased all of the securities in this transaction.

F8 · balance_after: After this transaction, Qualified Fund held 7,401,972 shares of the Issuer's Common Stock.

F1 · ownership.nature: The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interests therein.

Read SEC document
December 31, 2024 Filed Jan 2, 2025 18:17 UTC
EcoR1 Capital, LLCDirector · 10% owner
NODELMAN OLEGDirector · 10% owner
PurchaseCommon Stock 13,268 $12.93 $171,512.78
Disclosure

SEC source: 0000935836-25-000008 · ownership.xml · nonDerivative · entry 2

EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner

NODELMAN OLEG · CIK 0001454385 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Note

Disclosed balance after: 7,873,448

F5 · shares: Qualified Fund purchased all of the securities in this transaction.

F6 · balance_after: After this transaction, Qualified Fund held 7,395,326 shares of the Issuer's Common Stock.

F1 · ownership.nature: The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interests therein.

Read SEC document
December 30, 2024 Filed Jan 2, 2025 18:17 UTC
EcoR1 Capital, LLCDirector · 10% owner
NODELMAN OLEGDirector · 10% owner
PurchaseCommon Stock 65,184 $12.92 $842,059.95
Disclosure

SEC source: 0000935836-25-000008 · ownership.xml · nonDerivative · entry 1

EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner

NODELMAN OLEG · CIK 0001454385 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Note

Disclosed balance after: 7,860,180

F2 · shares: Qualified Fund purchased all of the securities in this transaction.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.71 to $12.9552, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote 3.

F4 · balance_after: After this transaction, Qualified Fund held 7,382,058 shares of the Issuer's Common Stock.

F1 · ownership.nature: The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interests therein.

Read SEC document
November 29, 2024 Filed Dec 3, 2024 21:35 UTC Exercise / conversionCommon Stock · Derivative 10,000 $0.00 Strike: $6.93 $0.00
Disclosure

SEC source: 0001415889-24-028094 · form4-12032024_091237.xml · derivative · entry 3

RENTON HOLLINGS · CIK 0001187333 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,925

Underlying: Common Stock · 10,000 shares

Expires 2025-07-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option grant was issued on July 6, 2015, is fully vested and exercisable until its expiration date of July 5, 2025.

F3 · balance_after: In addition to the remaining options to purchase 20,925 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 95,541 shares of common stock, which options vest according to their terms.

Read SEC document
November 29, 2024 Filed Dec 3, 2024 21:35 UTC SaleCommon Stock 10,000 $25.00 $250,000.00
Disclosure

SEC source: 0001415889-24-028094 · form4-12032024_091237.xml · nonDerivative · entry 2

RENTON HOLLINGS · CIK 0001187333 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,950

F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024. Mr. Renton holds various stock options that are expiring in 2025 and wished to put the plan in place to facilitate the orderly exercise of such options before their expiration.

Read SEC document
November 29, 2024 Filed Dec 3, 2024 21:35 UTC Exercise / conversionCommon Stock 10,000 $6.93 $69,300.00
Disclosure

SEC source: 0001415889-24-028094 · form4-12032024_091237.xml · nonDerivative · entry 1

RENTON HOLLINGS · CIK 0001187333 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,950

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 23, 2024 Filed Sep 24, 2024 20:18 UTC
Lizzul Paul F.Chief Medical Officer
Exercise / conversionCommon · Derivative 1,500 $0.00 Strike: $18.50 $0.00
Disclosure

SEC source: 0001415889-24-023900 · form4-09242024_080920.xml · derivative · entry 3

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common · 1,500 shares

Expires 2030-07-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on July 31, 2021, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

F3 · balance_after: In addition to the remaining options to purchase 85,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 297,610 shares of common stock, which options vest according to their terms.

Read SEC document
September 23, 2024 Filed Sep 24, 2024 20:18 UTC
Lizzul Paul F.Chief Medical Officer
SaleCommon Stock 1,500 $38.67 $58,005.00
Disclosure

SEC source: 0001415889-24-023900 · form4-09242024_080920.xml · nonDerivative · entry 2

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,398

F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2024.

Read SEC document
September 23, 2024 Filed Sep 24, 2024 20:18 UTC
Lizzul Paul F.Chief Medical Officer
Exercise / conversionCommon Stock 1,500 $18.50 $27,750.00
Disclosure

SEC source: 0001415889-24-023900 · form4-09242024_080920.xml · nonDerivative · entry 1

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,898

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 17, 2024 Filed Sep 17, 2024 18:44 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
SaleCommon Stock 3,780 $38.41 $145,190.93
Disclosure

SEC source: 0001415889-24-023551 · form4-09172024_100920.xml · nonDerivative · entry 5

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,240

F4 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated June 10, 2024.

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.05 to $38.98 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 16, 2024 Filed Sep 17, 2024 22:42 UTC
Lizzul Paul F.Chief Medical Officer
SaleCommon Stock 2,220 $38.93 $86,424.60
Disclosure

SEC source: 0001415889-24-023550 · form4-09172024_100907.xml · nonDerivative · entry 2

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,398

F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
September 16, 2024 Filed Sep 17, 2024 18:44 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $14.02 $0.00
Disclosure

SEC source: 0001415889-24-023551 · form4-09172024_100920.xml · derivative · entry 7

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 73,000

Underlying: Common Stock · 5,000 shares

Expires 2029-12-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The stock option vested and is exercisable as to 25% of the shares subject to the option on December 6, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

F8 · balance_after: In addition to the remaining options to purchase 73,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 355,310 shares of common stock, which options vest according to their terms.

Read SEC document
September 16, 2024 Filed Sep 17, 2024 18:44 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
SaleCommon Stock 6,500 $40.13 $260,845.00
Disclosure

SEC source: 0001415889-24-023551 · form4-09172024_100920.xml · nonDerivative · entry 4

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,020

F4 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated June 10, 2024.

Read SEC document
September 16, 2024 Filed Sep 17, 2024 18:44 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
Exercise / conversionCommon Stock 5,000 $14.02 $70,100.00
Disclosure

SEC source: 0001415889-24-023551 · form4-09172024_100920.xml · nonDerivative · entry 3

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,520

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 16, 2024 Filed Sep 17, 2024 18:44 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
SaleCommon Stock 2,220 $38.93 $86,424.60
Disclosure

SEC source: 0001415889-24-023551 · form4-09172024_100920.xml · nonDerivative · entry 2

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,520

F3 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
September 16, 2024 Filed Sep 17, 2024 22:41 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $20.16 $0.00
Disclosure

SEC source: 0001415889-24-023549 · form4-09172024_100933.xml · derivative · entry 6

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 80,600

Underlying: Common Stock · 10,000 shares

Expires 2030-07-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on July 15, 2021, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

F6 · balance_after: In addition to the remaining options to purchase 80,600 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 263,040 shares of common stock, which options vest according to their terms.

Read SEC document
September 16, 2024 Filed Sep 17, 2024 22:41 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
SaleCommon Stock 10,000 $40.13 $401,300.00
Disclosure

SEC source: 0001415889-24-023549 · form4-09172024_100933.xml · nonDerivative · entry 4

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,744

F3 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated June 14, 2024.

Read SEC document
September 16, 2024 Filed Sep 17, 2024 22:41 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 10,000 $20.16 $201,600.00
Disclosure

SEC source: 0001415889-24-023549 · form4-09172024_100933.xml · nonDerivative · entry 3

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,744

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 16, 2024 Filed Sep 17, 2024 22:41 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
SaleCommon Stock 2,220 $38.93 $86,424.60
Disclosure

SEC source: 0001415889-24-023549 · form4-09172024_100933.xml · nonDerivative · entry 2

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,744

F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
September 15, 2024 Filed Sep 17, 2024 22:45 UTC
Orwin John ADirector
Exercise / conversionRestricted Stock Unit · Derivative 1,300 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-023552 · form4-09172024_100957.xml · derivative · entry 2

Orwin John A · CIK 0001477384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,600

Underlying: Common Stock · 1,300 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · derivative.exercise_date: The RSUs shall vest as to 1/3 of the total shares on September 15, 2024, and thereafter vests as to 1/3 of the total RSUs on September 15, 2025; and as to 1/3 of the total RSUs on September 15, 2026, subject to the provision of services to the Company on each vesting date.

F2 · derivative.expiration_date: The RSUs shall vest as to 1/3 of the total shares on September 15, 2024, and thereafter vests as to 1/3 of the total RSUs on September 15, 2025; and as to 1/3 of the total RSUs on September 15, 2026, subject to the provision of services to the Company on each vesting date.

Read SEC document
September 15, 2024 Filed Sep 17, 2024 22:45 UTC
Orwin John ADirector
Exercise / conversionCommon Stock 1,300 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-023552 · form4-09172024_100957.xml · nonDerivative · entry 1

Orwin John A · CIK 0001477384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,335

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
September 14, 2024 Filed Sep 17, 2024 22:42 UTC
Lizzul Paul F.Chief Medical Officer
Exercise / conversionRestricted Stock Unit · Derivative 6,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-023550 · form4-09172024_100907.xml · derivative · entry 3

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: 50% of the total restricted stock units vested on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: 50% of the total restricted stock units vested on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
September 14, 2024 Filed Sep 17, 2024 22:42 UTC
Lizzul Paul F.Chief Medical Officer
Exercise / conversionCommon Stock 6,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-023550 · form4-09172024_100907.xml · nonDerivative · entry 1

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,618

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
September 14, 2024 Filed Sep 17, 2024 18:44 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 6,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-023551 · form4-09172024_100920.xml · derivative · entry 6

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F6 · derivative.exercise_date: 50% of the total restricted stock units vested on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F6 · derivative.expiration_date: 50% of the total restricted stock units vested on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
September 14, 2024 Filed Sep 17, 2024 18:44 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
Exercise / conversionCommon Stock 6,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-023551 · form4-09172024_100920.xml · nonDerivative · entry 1

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,740

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · balance_after: Includes 1,500 shares acquired under the Employee Stock Purchase Plan as of May 15, 2024.

Read SEC document
September 14, 2024 Filed Sep 17, 2024 22:41 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 6,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-023549 · form4-09172024_100933.xml · derivative · entry 5

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F4 · derivative.exercise_date: 50% of the total restricted stock units vested on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F4 · derivative.expiration_date: 50% of the total restricted stock units vested on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
September 14, 2024 Filed Sep 17, 2024 22:41 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 6,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-023549 · form4-09172024_100933.xml · nonDerivative · entry 1

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,964

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
August 14, 2024 Filed Aug 16, 2024 20:09 UTC
Lizzul Paul F.Chief Medical Officer
Exercise / conversionCommon · Derivative 2,000 $0.00 Strike: $18.50 $0.00
Disclosure

SEC source: 0001415889-24-021452 · form4-08162024_080835.xml · derivative · entry 3

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 86,500

Underlying: Common · 2,000 shares

Expires 2030-07-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on July 31, 2021, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

F3 · balance_after: In addition to the remaining options to purchase 86,500 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 297,610 shares of common stock, which options vest according to their terms.

Read SEC document
August 14, 2024 Filed Aug 16, 2024 20:09 UTC
Lizzul Paul F.Chief Medical Officer
SaleCommon Stock 2,000 $40.00 $80,000.00
Disclosure

SEC source: 0001415889-24-021452 · form4-08162024_080835.xml · nonDerivative · entry 2

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,618

F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2023.

Read SEC document
August 14, 2024 Filed Aug 16, 2024 20:09 UTC
Lizzul Paul F.Chief Medical Officer
Exercise / conversionCommon Stock 2,000 $18.50 $37,000.00
Disclosure

SEC source: 0001415889-24-021452 · form4-08162024_080835.xml · nonDerivative · entry 1

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,618

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 14, 2024 Filed Aug 16, 2024 16:04 UTC PurchaseCommon Stock 273,972 $36.50 $9,999,978.00
Disclosure

SEC source: 0000935836-24-000532 · ownership.xml · nonDerivative · entry 1

EcoR1 Capital, LLC · CIK 0001587114 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Notes

Disclosed balance after: 7,794,996

F2 · shares: Qualified Fund purchased all of the shares acquired in this transaction.

F3 · balance_after: After this transaction, Qualified Fund holds 7,316,874 shares of Issuer's Common Stock.

F1 · ownership.nature: The filers are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund ("the Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold shares directly for the benefit of their investors. EcoR1 may be deemed to beneficially own the shares indirectly as the investment adviser to the Fund, and Mr. Nodelman may be deemed to beneficially own them indirectly as the control person of EcoR1. The filers disclaim beneficial ownership of the shares except to the extent of their pecuniary interest therein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.